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Abstract
Objectives:  Several investigators have reported that clinical improvements of patients with
rheumatoid arthritis (RA), from participating in therapeutic diet intervention studies, have been
accompanied by loss of body weight. This has raised the question whether weight reduction per se
can improve RA. In order to test this hypothesis, three previously conducted diet intervention
studies, comprising 95 patients with RA, were pooled. Together with Age, Gender, and Disease
Duration, change during the test period in body weight, characterised dichotomously as reduction
or no reduction (dicho∆ Body Weight), as well as Diet (dichotomously as ordinary diet or test diet),
were the independent variables. Dependent variables were the difference (∆ ) from baseline to
conclusion of the study in five different disease outcome measures. ∆ ESR and ∆ Pain Score were
both characterised numerically and dichotomously (improvement or no improvement). ∆ Acute
Phase Response, ∆ Physical Function, and ∆ Tender Joint Count were characterised dichotomously
only. Multiple logistic regression was used to analyse associations between the independent and the
disease outcome variables.
Results: Statistically significant correlations were found between Diet and three disease outcome
variables i.e. ∆ Acute-Phase Response, ∆ Pain Score, and ∆ Physical Function. ∆  Body Weight was
univariately only correlated to ∆ Acute-Phase Response but not significant when diet was taken into
account.
Conclusion:  Body weight reduction did not significantly contribute to the improvement in
rheumatoid arthritis when eating lacto-vegetarian, vegan or Mediterranean diets.
Introduction
We have recently found that patients with rheumatoid
arthritis (RA) improved significantly in disease activity
from eating a modified Cretan Mediterranean diet (MD)
[1]. Improvement was seen in 9 of 14 efficacy variables.
The RA disease activity as measured by the "Disease
Published: 04 May 2005
Nutrition Journal 2005, 4:15 doi:10.1186/1475-2891-4-15
Received: 04 October 2004
Accepted: 04 May 2005
This article is available from: http://www.nutritionj.com/content/4/1/15
© 2005 Sköldstam et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Nutrition Journal 2005, 4:15 http://www.nutritionj.com/content/4/1/15
Page 2 of 6
(page number not for citation purposes)
Activity Score" DAS28 [2] was reduced by 13 %. In com-
parison the control group showed no change. The favour-
able outcome of the diet intervention group indicated that
the MD had been suppressive to RA inflammation. We
believe that the anti inflammatory effect of the MD was
mediated by its different lipid profile [1] in conjunction
with its high content of fresh fruits and green vegetables.
However, at the end of the experiment the patients of the
MD group, but not the control group, had lost 3 kg in
weight (p < 0.001 between groups), although our ambi-
tion had been to prescribe a diet that was isocaloric com-
pared to the patients' previous food intake. This
unexpected weight loss raised the question whether a
reduced energy intake, could have been yet another anti-
inflammatory factor? That diet intervention studies may
induce unexpected weight reduction to patients with RA is
a finding shared by others [3-9]. Some researchers [7,8]
have even reported a statistically significant correlation
between change in body weight with change in arthritis
measurements.
The aim of the present study was to investigate whether
weight reduction could have anti inflammatory effect on
RA. Data from three previously performed diet interven-
tion studies were pooled for the analysis.
Methods
Design
Data from three different diet intervention studies, which
we had previously conducted on patients with rheuma-
toid arthritis [1,3,4] were pooled and reanalysed.
Two studies (1st and 3rd) had a prospective, randomised,
and parallel design. The 2nd was a prospective, cross over
study. Nor the participating patients or the clinical out-
come valuators were blinded with respect to the study
designs.
Patients
The pooled patient material comprises 95 Caucasians
with RA according to the American College of Rheumatol-
ogy (ACR) criteria from 1984. All but one had active dis-
ease. The three populations showed equal distributions
with respect to sex, age, disease duration, functional
capacity and stage of RA disease (Table 1).
The original studies
In the first study [3] 24 RA patients concluded the trial. 14
tested a lacto-vegetarian diet, and 10 were controls. Eight
from the diet group reported less pain at the end of the
experiment. As a group they lost 2.6 kg (p < 0.001) in
body weight, but showed no statistically significant
change in disease outcome measures. The control group
stayed unchanged.
In the second study [4], which had a cross over design, 20
RA patients concluded the trial. All were initially followed
for a control period of two or five months, 13 and 7
patients, respectively. Thereafter, all patients adopted a
vegan diet for 4 months. During the vegan diet period the
group of 20 patients obtained statistically significant
reduction in pain score, increase in functional capacity,
and a loss of 4.8 kg (p < 0.001) in body weight. No change
took place during the control periods. Only those 7
patients who had had a five months long control period
were included as controls in the present pooled analysis.
In the third study [1] 51 RA-patients concluded the trial.
26 tested a Cretan Mediterranean diet (MD) and 25 were
controls. As a group the MD patients improved in 9 out of
14 disease outcome measures and lost 3 kg (p < 0.001) in
body weight.
The pooled patient material
Number of patients from the three studies is 95. Seven of
these patients were studied in a cross-over design (2nd
study), and therefore, included both in the control and
the intervention group giving a total number of 95+7. The
patient demographics are shown in Table 1.
Diets
The diets tested were lacto-vegetarian [3], strictly vegetar-
ian, vegan [4] and a modified Cretan Mediterranean diet
[1].
Table 1: Baseline characteristics of patients who completed the trials.
Diet group (n = 60) Control group (n = 42)
Age (years) 54.5 (33–73) 57.0 (35–75)
Gender (M/F)* 11/49 7/35
Weight (kg) 72.1 (40–109) 69.4 (41–102)
Disease duration (years) 13.0 (0.5–59) 11.9 (2–35)
Footnotes to table:
Data are presented as mean (range) unless otherwise stated.
* Number of male and females, respectivelyNutrition Journal 2005, 4:15 http://www.nutritionj.com/content/4/1/15
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Measurements
Five different measures of RA disease activity were identi-
fied, that had been assessed in all three studies. Two had
been identically assessed in all three studies. These were
the ESR (the Westergren erythrocyte sedimentation rate),
and the Pain Score, which was the patient's self perceived
pain severity as evaluated on a visual analogue scale (VAS,
0–100 mm).
The three measures, which were not similarly assessed and
therefore not directly comparable, were firstly the blood
plasma Acute-Phase Response [10], which in the 1st study
was measured with the reaction in plasma concentration
of orosomucoid, and in the 2nd and 3rd with the corre-
sponding reaction of C-reactive protein (CRP). The sec-
ond was Physical Function as evaluated and recorded by
the patient with a graded questionnaire of difficulties in
performing specified tasks of daily living. A locally con-
structed questionnaire was used in the 1st study, a not val-
idated Swedish version of the Stanford-health assessment
questionnaire (HAQ) in the 2nd study, and the official
Swedish version of HAQ [11] in the third study. The third
dissimilarly assessed outcome measure was the Tender
Joint Count [2], which in the 1st study was the Ritchie
joint index [12], and in the 2nd and 3rd study was the
number of tender joints from palpation of 40, and 28
peripheral joints, respectively.
Due to different techniques of assessing these last three
measures, change (∆ ) obtained with these variables from
baseline to the end of the experiments, could not be
directly compared from the numerical results. These
changes had to be converted into dichotomous values to
enable a relevant statistical analysis. Change from base-
line to the end of each study was thus characterised as
improvement, or no improvement. These dichotomous
variables are here called: dicho∆ Acute-Phase Response,
dicho∆ Physical Function and dicho∆ Tender Joint Count.
Tested variables
Patient demographics
Gender, age and disease duration were used as independ-
ent variables. Age was characterised with respect to the
median value, dichotomously, as <56 yrs or ≥  56 yrs
(dichoAge). Similarly, disease duration was characterised
as <9.5 yrs or ≥  9.5 yrs (dichoDisease Duration). Also the
diet intervention was handled as an independent variable,
and was characterised dichotomously, either as Case
(lacto-vegetarian, vegan diet and Mediterranean) or as
Control. The only independent outcome variable was the
difference (∆ ) from baseline to end of the study in body
weight, and was characterised dichotomously as reduc-
tion or no reduction (dicho∆ Body Weight).
Disease outcome variables
For evaluating effects that the dietary interventions might
have had on RA disease activity, the difference (∆ ) from
baseline to end of study, in each of the five disease meas-
ures was calculated. For ESR and for Pain Score this was
done numerically (num∆ ESR and num∆ Pain Score) but
also, in the logistic regression, dichotomously character-
ised as improvement, or no improvement (dicho∆ ESR
and dicho∆ Pain Score, respectively).
The other three RA disease measures were only handled
dichotomously. They were: dicho∆ Acute-Phase Response,
dicho∆ Physical Function and dicho∆ Tender Joint Count,
and were characterized as improvement /no
improvement.
Statistics
Baseline characteristics of the two diet groups were tested
with non parametric tests (Mann-Whitney's U-test, and
for gender Fischer's exact test; Table 1). Student's t-test and
Mann-Whitney's nonparametric U-test were used to ana-
lyse group differences of change in numerical values of
∆ ESR and ∆ Pain Score, respectively.
The dichotomous variables were only analysed with logis-
tic regression. All independent variables considered
potentially significant were initially included in the model
followed by a step-wise deletion of the least significant
variable until a significant level of 0.05 or less. The statis-
tical analyses were made using a commercially available
computer programme (STATISTICA, StatSoft®, Tulsa,
USA) and a p-value less than 0.05 was considered statisti-
cally significant.
Results
Baseline values before diet intervention
At baseline, no significant differences in Age, Gender,
Body Weight or Disease Duration were found between the
two groups (Table 1) or in the disease measures ESR and
Pain Score.
Change obtained from baseline to the end of the diet 
intervention period
Univariate analysis
Gender, Age, or Disease Duration were not associated
with any of the outcome variables (p-values 0.2–1.0; uni-
variate logistic regression; Table 2). The diet regimens ren-
dered the diet group a weight fall of on average 3.5 kg,
which is highly significant compared to the controls, who
lost 0.1 kg (p < 0.001; Student's t-test). Body Weight
reduction was univariately only correlated to
improvement in dicho∆ Acute-Phase Response (Table 2).
Of the other outcome variables, ESR raised from 30.7 +/-
22 to 31.5 +/- 23 for the diet group and from 34.1 +/- 21
to 36.1 +/- 27 for the control group. These changes wereNutrition Journal 2005, 4:15 http://www.nutritionj.com/content/4/1/15
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not statistically significant (Student's t-test or Mann-Whit-
ney's U-test) and did not correlate significantly with
∆ Body Weight or dicho∆ Body Weight. These findings
were in accordance with the univariate logistic regression
using the dichotomous variables (Table 2).
∆ Pain Score showed a decrease of 10 units for the diet
group and an increase of 2 units for the control group.
This difference between groups was statistically significant
(p = 0.011; Mann-Whitney's U-test) and was confirmed
with the dicho∆ Pain Score difference (p = 0.007) (Table
2).
Using logistic regression, there were statistically signifi-
cant correlations between diet and the results from three
outcome variables. These were the dicho∆ Acute-Phase
Response, the dicho∆ Pain Score and the dicho∆ Physical
Function, but not with the dicho∆ ESR or the dicho∆
Tender Joint Count (Table 2).
Multivariate analyses
The significant correlations using multiple logistic regres-
sion were limited to the association of dichoDiet to the
three outcome variables dicho∆ Acute-Phase Response,
the dicho∆ Pain Score and the dicho∆ Physical Function,
but not to the dicho∆ ESR or the dicho∆ Tender Joint
Count (Table 3). Hence, body weight reduction (dicho∆
Body Weight) was not statistically significantly coupled to
any outcome variables when diet was taken into account.
Discussion
The time intervals between the 1st and 2nd, and between
the 2nd and 3rd studies were approximately ten years. One
of the authors was local clinical research coordinator for
all three projects. The studies were conducted in three dif-
ferent regions of Sweden. However, the patient popula-
tions were very much alike, as all patients were recruited
from similar clinical settings at the central out patient
rheumatology clinic of each region.
In all three studies the patients had been aggressively
treated pharmacologically according to the internation-
ally recommended guidelines that were prevailing at the
time of each study. As a consequence of the more efficient
disease modifying drugs of the 1990ths, the arthritis activ-
ity was better controlled in the 3rd study than in the two
earlier studies. With all three studies the participating
patients had showed active interest for the kind of diet
that was under investigation. At the time of the first two
studies, vegetarian diets were advocated by laymen, while
in the 1990ths much attention was focused on Mediterra-
nean diets. Although different, these three diets shared
some common characteristics which we believe were of
importance with respect to control of inflammation.
Compared to ordinary western diets they contained less of
saturated fats from meat and dairy products. They had
more of fresh fruits and of green vegetables. The MD was
also rich in fats from sea foods, which was not a feature of
the two vegetarian variants.
Table 2: Univariate logistic regression results (Odds Ratios (OR) and corresponding p-values), showing the associations between 
Gender, Age, Diet, Disease Duration and ∆ Body Weight on the one hand, and the five different dicho∆  outcome variables on the other. 
Bolded values are statistically significant.
Independent variable
OR Gender Age (yrs) Diet Duration (yrs) ∆ Body Weight
Effect variable M F p <56 ≥ 56 p Control Case p <9.5 ≥ 9.5 p <0 ≥ 0p
dicho∆ ESR 1.00 1.02 0.98 1.00 1.22 0.62 1.00 1.29 0.55 1.00 1.00 1.00 1.00 1.64 0.29
dicho∆ Acute-PR 1.00 0.60 0.33 1.00 0.74 0.45 1.00 3.27 0.007 1.00 1.17 0.69 1.00 2.85 0.03
dicho∆ Pain Score 1.00 0.47 0.18 1.00 0.65 0.29 1.00 3.43 0.004 1.00 1.27 0.55 1.00 2.10 0.10
dicho∆ Physic. F 1.00 0.86 0.78 1.00 0.74 0.45 1.00 4.22 0.002 1.00 1.38 0.42 1.00 2.16 0.10
dicho∆ Tender JC 1.00 0.93 0.90 1.00 1.54 0.28 1.00 1.54 0.29 1.00 1.22 0.62 1.00 1.77 0.20
Footnotes to table:
ESR = The Westergren erythrocyte sedimentation rate
Acute-PR = The Acute-Phase Response (Orosomucoid or C-reactive protein (CRP))
Pain Score = the patient's self perceived pain severity as evaluated on a visual analogue scale
Physic. F = Physical Function assessed by self completed questionnaires on the degree of difficulty in performing specified tasks of daily living
Tender JC = Tender Joint Count = number of painful joints at rest with pressure.Nutrition Journal 2005, 4:15 http://www.nutritionj.com/content/4/1/15
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Another consequence of the time difference between the
three studies was that the RA measures were not com-
pletely identical. They had successively been changed in
line with the international recommendations of good sci-
entific standards. Thus, comparable absolute baseline esti-
mations of pain-score, acute phase response, physical
function or tender joint count were not available due to
their different definitions during the three intervention
studies. Nevertheless, as explained in "methods", for the
present analysis the outcome results of these variables
were well defined, as they were dichotomously character-
ised as improvement, or no improvement.
The cross over design of the 2nd study, with 7 patients
assessed first as controls and later as diet patients, weakens
the statistical power of the pooled statistical analysis only
marginally.
In the three studies of ours each intervention i.e. with
lacto-vegetarian, vegan or modified Cretan Mediterranean
diet had rendered the patients a weight fall of on the aver-
age 2.4 kg over a trial length of 3–4 months. In the pooled
analysis of change in body weight versus change in clinical
outcome measurements the results were fairly clear. Apart
from a univariate correlation between improvement in
acute phase response and reduction in body weight, no
statistically significant correlation was seen with the mul-
tiple logistic regression analysis between weight loss and
the concomitantly obtained change in RA disease meas-
urements. Thus the body weight loss seemed to have had
no statistical significant anti inflammatory effect. How-
ever, although the number of patients was increased from
pooling three different studies, the total amount of data
was still relatively small. Therefore a possible anti inflam-
matory effect of weight reduction should not be com-
pletely discarded. Furthermore, the potential effect that
weight reduction may have, should ideally be studied by
itself, i.e. the test and control diets should differ only with
respect to their contents of energy.
As for comparison of diet intervention versus control diet,
the multiple logistic regression analysis, showed highly
significant statistical correlations between diet interven-
tion and improvement in RA outcome variables. These
data indicate that dietary factors may have a potential role
in treatment of RA. With regards to vegan diets, our obser-
vation is supported by the results of at least two independ-
ent, randomised and controlled studies [6,9].
Of course, the beneficial factors that the tested diets share
need to be identified. A noteworthy candidate is their rel-
atively low content of saturated fats [13]. Another is their
high content of fresh fruits and vegetables.
Patients with active RA tend to have an abnormally
increased peripheral insulin resistance [14]. Deliberate
weight reduction in a group of patients with gout [15] was
accompanied by reduction of insulin resistance and less
numbers of inflammatory events. Whether this strategy
for gout would work for patients with RA, and improve
their arthritis, is an important clinical question. Some
recent observational data indicate that overweight and
obesity might be a risk factor for RA [16]. From experi-
mental studies in mice [17] it is known that long-term
pure energy under-nutrition has anti-inflammatory
effects. In humans, deliberately undertaken short term
fasting is well known to induce immune suppression and
improvement in RA disease activity [18]. There are no
controlled long-term studies of reduced energy intake
without mal-nutrition on patients with RA. However,
Iwasahige et al. [19] recently conducted a regiment for 54
days of caloric restriction combined with fasting in ten
patients with RA. The patients lost in weight, and interest-
ingly, the composite disease activity score of Lansbury was
significantly reduced.
Table 3: Multiple logistic regression results (Odds ratios (OR) and 95% confidence intervals(95% CI)), showing the association between 
the only statistically significant independentvariable, diet on the one hand, and the three disease outcome variables, which 
showedstatistically significant correlation to type of diet, on the other.
Control diet Intervention diet
Imp/no imp Imp (%) OR Imp/no imp Imp (%) OR 95% CI p
dicho∆ Acute PR 12/30 29 1.00 34/26 57 3.27 1.39 – 7.67 0.007
dicho∆ Pain Score 17/25 40 1.00 42/18 70 3.43 1.49 – 7.93 0.005
dicho∆ Physic. F 10/31 24 1.00 34/25 58 4.22 1.73 – 10.3 0.002
Footnotes to table:
ESR = The Westergren erythrocyte sedimentation rate
Acute-PR = The Acute-Phase Response (orosomucoid or C-reactive protein (CRP))
Pain Score = the patient's self perceived pain severity as evaluated on a visual analogue scale
Physic. F = Physical Function assessed by self completed questionnaires on the degree of difficulty in performing specified tasks of daily living.Publish with BioMed Central    and   every 
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We know of two other small studies on deliberately
undertaken weight reduction in patients with RA. In an
uncontrolled pilot study [20] with 19 overweight patients
with RA, Danish researchers had instructed the patients to
lower their energy intake by 30% to achieve weight reduc-
tion. After a period of 12 weeks, the mean weight loss was
4.5 kg. No change was obtained in joint pain, morning
stiffness, number of tender joints, or in sedimentation
rate. Neither did Gordon et al. from their uncontrolled
pilot study report any short-term favourable effects from
assisting obese RA patients to reduce their body weight
[21].
In conclusion, it seems as weight reduction strategies have
little if any influence on RA inflammation. Perhaps this is
not surprising with regards to what is already known from
research on the metabolic syndrome and on atheroscle-
rotic vascular disease, where isolated overweight is rank as
a less important factor of risk [22].
Before conclusion of this discussion we need to remember
that there is a controversy in letting patients with RA test
an experimental regiment, which would involve pro-
longed reduction of their energy intake. During the course
of RA most RA patients including those with overweight
will develop a muscle wasting condition known as rheu-
matoid cachexia [22]. Although not directly fatal, this
form of cachexia is believed to contribute to co-morbidity
and reduced life expectancy. It is caused by the rheuma-
toid inflammation by itself and is refractory to nutritional
therapy.
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